![Pharmaceuticals | Free Full-Text | Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy Pharmaceuticals | Free Full-Text | Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-01573/article_deploy/html/images/pharmaceuticals-15-01573-g001.png)
Pharmaceuticals | Free Full-Text | Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
![Cancers | Free Full-Text | Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? Cancers | Free Full-Text | Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?](https://www.mdpi.com/cancers/cancers-13-05204/article_deploy/html/images/cancers-13-05204-g001.png)
Cancers | Free Full-Text | Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?
Olga Mashiah-Vladimirova - Information Technology Quality Assurance Expert - Teva Pharmaceuticals | LinkedIn
![Cancers | Free Full-Text | Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Cancers | Free Full-Text | Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory](https://www.mdpi.com/cancers/cancers-14-00521/article_deploy/html/images/cancers-14-00521-g001a-550.jpg)
Cancers | Free Full-Text | Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory
Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated inte
![Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort - The Lancet Respiratory Medicine Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/7389893d-7f07-4f35-bd90-4ee8ede998c9/gr2_lrg.jpg)
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort - The Lancet Respiratory Medicine
![Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial - The Lancet Haematology Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial - The Lancet Haematology](https://www.thelancet.com/cms/attachment/e07bba78-83c8-43ca-ad6c-a9c03cb1f620/gr2_lrg.jpg)
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial - The Lancet Haematology
![Frontiers | Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance Frontiers | Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance](https://www.frontiersin.org/files/Articles/609292/fpain-01-609292-HTML/image_m/fpain-01-609292-g001.jpg)
Frontiers | Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance
![Hydrating Probiotic Face Cream, "Yoghurt of Bulgaria", 100 ml, Biofresh -- S. & S. TRIA ENNIARIA TRADING LTD Hydrating Probiotic Face Cream, "Yoghurt of Bulgaria", 100 ml, Biofresh -- S. & S. TRIA ENNIARIA TRADING LTD](https://tria999enniaria.com/userfiles/productlargeimages/product_6431.jpg)